

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.32754486 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.32754486 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 6.32754486 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 6.32754486 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 6.32754486 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.32754486 |
| 7 | response to peptidoglycan (GO:0032494) | 5.06452668 |
| 8 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.65190928 |
| 9 | glycosphingolipid catabolic process (GO:0046479) | 4.63905814 |
| 10 | macrophage activation involved in immune response (GO:0002281) | 4.61099783 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 4.60605611 |
| 12 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.57334382 |
| 13 | positive regulation of interferon-alpha production (GO:0032727) | 4.47810304 |
| 14 | amino sugar catabolic process (GO:0046348) | 4.47638431 |
| 15 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.42464261 |
| 16 | regulation of interferon-alpha production (GO:0032647) | 4.35977808 |
| 17 | oligosaccharide catabolic process (GO:0009313) | 4.16479505 |
| 18 | glycolipid catabolic process (GO:0019377) | 4.15797991 |
| 19 | respiratory burst (GO:0045730) | 4.01026874 |
| 20 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.99072802 |
| 21 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.93189952 |
| 22 | response to host immune response (GO:0052572) | 3.93189952 |
| 23 | immunoglobulin mediated immune response (GO:0016064) | 3.91471480 |
| 24 | regulation of mononuclear cell migration (GO:0071675) | 3.90625284 |
| 25 | N-acetylneuraminate metabolic process (GO:0006054) | 3.86473822 |
| 26 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.84226994 |
| 27 | response to muramyl dipeptide (GO:0032495) | 3.76069138 |
| 28 | wound healing, spreading of epidermal cells (GO:0035313) | 3.75529795 |
| 29 | positive regulation of heat generation (GO:0031652) | 3.75528219 |
| 30 | * positive regulation of chemokine biosynthetic process (GO:0045080) | 3.73215877 |
| 31 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.71434926 |
| 32 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.68414266 |
| 33 | negative regulation of interleukin-12 production (GO:0032695) | 3.67644002 |
| 34 | ceramide catabolic process (GO:0046514) | 3.64767788 |
| 35 | protein localization to endosome (GO:0036010) | 3.62114657 |
| 36 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.59500005 |
| 37 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.58166475 |
| 38 | response to host (GO:0075136) | 3.58166475 |
| 39 | response to host defenses (GO:0052200) | 3.58166475 |
| 40 | response to thyroid hormone (GO:0097066) | 3.58152190 |
| 41 | regulation of fever generation (GO:0031620) | 3.58141383 |
| 42 | barbed-end actin filament capping (GO:0051016) | 3.57476368 |
| 43 | regulation of cholesterol storage (GO:0010885) | 3.52556211 |
| 44 | regulation of macrophage chemotaxis (GO:0010758) | 3.52357635 |
| 45 | regulation of podosome assembly (GO:0071801) | 3.50653506 |
| 46 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.50234457 |
| 47 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.43908763 |
| 48 | microglial cell activation (GO:0001774) | 3.35565538 |
| 49 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.34399487 |
| 50 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.31400879 |
| 51 | macrophage activation (GO:0042116) | 3.30308828 |
| 52 | membrane lipid catabolic process (GO:0046466) | 3.26861085 |
| 53 | T-helper 1 type immune response (GO:0042088) | 3.24939487 |
| 54 | granulocyte activation (GO:0036230) | 3.22564977 |
| 55 | apoptotic cell clearance (GO:0043277) | 3.21693954 |
| 56 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.19936471 |
| 57 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.19436227 |
| 58 | cell adhesion mediated by integrin (GO:0033627) | 3.17028739 |
| 59 | detection of other organism (GO:0098543) | 3.16451438 |
| 60 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.16398360 |
| 61 | positive regulation of antigen processing and presentation (GO:0002579) | 3.15286438 |
| 62 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.14626454 |
| 63 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.12260742 |
| 64 | sphingolipid catabolic process (GO:0030149) | 3.11633457 |
| 65 | positive regulation of interferon-beta production (GO:0032728) | 3.11399112 |
| 66 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.09475641 |
| 67 | detection of molecule of bacterial origin (GO:0032490) | 3.08140387 |
| 68 | reactive oxygen species biosynthetic process (GO:1903409) | 3.07414506 |
| 69 | regulation of monocyte chemotaxis (GO:0090025) | 3.06913250 |
| 70 | detection of external biotic stimulus (GO:0098581) | 3.06157256 |
| 71 | * regulation of mast cell degranulation (GO:0043304) | 3.03099767 |
| 72 | * low-density lipoprotein particle clearance (GO:0034383) | 3.02839859 |
| 73 | regulation of antigen processing and presentation (GO:0002577) | 2.98519052 |
| 74 | natural killer cell mediated immunity (GO:0002228) | 2.96537074 |
| 75 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.96537074 |
| 76 | positive regulation of p38MAPK cascade (GO:1900745) | 2.96357607 |
| 77 | negative regulation of lipid storage (GO:0010888) | 2.94916557 |
| 78 | B cell mediated immunity (GO:0019724) | 2.94755527 |
| 79 | positive regulation of cholesterol efflux (GO:0010875) | 2.93586549 |
| 80 | hyaluronan catabolic process (GO:0030214) | 2.92581709 |
| 81 | myeloid cell activation involved in immune response (GO:0002275) | 2.92260316 |
| 82 | * regulation of leukocyte degranulation (GO:0043300) | 2.90990801 |
| 83 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.90217734 |
| 84 | wound healing, spreading of cells (GO:0044319) | 2.90149354 |
| 85 | cellular extravasation (GO:0045123) | 2.89533424 |
| 86 | chronic inflammatory response (GO:0002544) | 2.88250787 |
| 87 | leukocyte aggregation (GO:0070486) | 2.87725494 |
| 88 | superoxide anion generation (GO:0042554) | 2.87519757 |
| 89 | detection of bacterium (GO:0016045) | 2.87297111 |
| 90 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.86095480 |
| 91 | adenosine receptor signaling pathway (GO:0001973) | 2.85565437 |
| 92 | virion attachment to host cell (GO:0019062) | 2.85431958 |
| 93 | adhesion of symbiont to host cell (GO:0044650) | 2.85431958 |
| 94 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.83599055 |
| 95 | neutrophil activation (GO:0042119) | 2.83351476 |
| 96 | positive regulation of extracellular matrix organization (GO:1903055) | 2.82711327 |
| 97 | response to laminar fluid shear stress (GO:0034616) | 2.80798927 |
| 98 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.80752096 |
| 99 | regulation of early endosome to late endosome transport (GO:2000641) | 2.79805105 |
| 100 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.79431749 |
| 101 | mannose metabolic process (GO:0006013) | 2.78299862 |
| 102 | peptide catabolic process (GO:0043171) | 2.77698274 |
| 103 | regulation of superoxide anion generation (GO:0032928) | 2.77617665 |
| 104 | regulation of heat generation (GO:0031650) | 2.76867675 |
| 105 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.76259893 |
| 106 | regulation of macrophage cytokine production (GO:0010935) | 2.75109907 |
| 107 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.73575955 |
| 108 | myeloid dendritic cell differentiation (GO:0043011) | 2.73495221 |
| 109 | macrophage differentiation (GO:0030225) | 2.72714765 |
| 110 | negative regulation of cell killing (GO:0031342) | 2.72384865 |
| 111 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.72384865 |
| 112 | monocyte chemotaxis (GO:0002548) | 2.71869576 |
| 113 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.70977048 |
| 114 | * regulation of mast cell activation involved in immune response (GO:0033006) | 2.70930183 |
| 115 | negative regulation of interleukin-6 production (GO:0032715) | 2.70480202 |
| 116 | positive regulation of leukocyte degranulation (GO:0043302) | 2.70228578 |
| 117 | eosinophil chemotaxis (GO:0048245) | 2.68195594 |
| 118 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.67961310 |
| 119 | I-kappaB phosphorylation (GO:0007252) | 2.67505877 |
| 120 | * regulation of chemokine biosynthetic process (GO:0045073) | 2.66919774 |
| 121 | pinocytosis (GO:0006907) | 2.66545942 |
| 122 | detection of biotic stimulus (GO:0009595) | 2.65529037 |
| 123 | neutrophil chemotaxis (GO:0030593) | 2.63186275 |
| 124 | eosinophil migration (GO:0072677) | 2.63102899 |
| 125 | cellular response to interferon-alpha (GO:0035457) | 2.62255435 |
| 126 | leukocyte cell-cell adhesion (GO:0007159) | 2.61505765 |
| 127 | positive regulation of mast cell activation (GO:0033005) | 2.61164256 |
| 128 | decidualization (GO:0046697) | 2.61163115 |
| 129 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.61052501 |
| 130 | NIK/NF-kappaB signaling (GO:0038061) | 2.60813017 |
| 131 | regulation of integrin activation (GO:0033623) | 2.60451414 |
| 132 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.60266184 |
| 133 | * regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.59953777 |
| 134 | phagosome maturation (GO:0090382) | 2.59793551 |
| 135 | * positive regulation of chemokine production (GO:0032722) | 2.59322405 |
| 136 | positive regulation of leukocyte apoptotic process (GO:2000108) | 2.58555104 |
| 137 | positive regulation of interleukin-6 production (GO:0032755) | 2.57477058 |
| 138 | adhesion of symbiont to host (GO:0044406) | 2.57077059 |
| 139 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.56868524 |
| 140 | positive regulation of mast cell degranulation (GO:0043306) | 2.56868524 |
| 141 | stress fiber assembly (GO:0043149) | 2.56810105 |
| 142 | positive regulation of lipid storage (GO:0010884) | 2.56606788 |
| 143 | positive regulation of receptor recycling (GO:0001921) | 2.56400297 |
| 144 | * myeloid cell homeostasis (GO:0002262) | 2.56003004 |
| 145 | germinal center formation (GO:0002467) | 2.55736708 |
| 146 | neutrophil migration (GO:1990266) | 2.55725392 |
| 147 | negative regulation of granulocyte differentiation (GO:0030853) | 2.54389476 |
| 148 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.54095436 |
| 149 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.53726616 |
| 150 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.53726616 |
| 151 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.53472828 |
| 152 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.52356241 |
| 153 | keratan sulfate catabolic process (GO:0042340) | 2.51881718 |
| 154 | cellular response to lipopolysaccharide (GO:0071222) | 2.51212824 |
| 155 | regulation of T cell tolerance induction (GO:0002664) | 2.47270077 |
| 156 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.44718350 |
| 157 | modulation by symbiont of host cellular process (GO:0044068) | 2.44351429 |
| 158 | response to acidic pH (GO:0010447) | 2.42010286 |
| 159 | lytic vacuole organization (GO:0080171) | 2.40810401 |
| 160 | lysosome organization (GO:0007040) | 2.40810401 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.30974033 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.18927514 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.50420472 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.42022289 |
| 5 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.65056364 |
| 6 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.49925838 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.49286627 |
| 8 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.45460260 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.35556452 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.33333704 |
| 11 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.20682185 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.96905535 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.66510879 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.54599287 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.54302266 |
| 16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.51434542 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.44439515 |
| 18 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.23479981 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.21582200 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.98354137 |
| 21 | * TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.97935922 |
| 22 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.92508975 |
| 23 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.91661841 |
| 24 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.88218456 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.85591758 |
| 26 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.85324888 |
| 27 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.83449726 |
| 28 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.78453568 |
| 29 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.78192277 |
| 30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.72487072 |
| 31 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.69404121 |
| 32 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.65449968 |
| 33 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.64414406 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.62491751 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.61855047 |
| 36 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.59863486 |
| 37 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.58957170 |
| 38 | GATA1_19941826_ChIP-Seq_K562_Human | 1.57624390 |
| 39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.54709549 |
| 40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.53532526 |
| 41 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.52298064 |
| 42 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.49237830 |
| 43 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.49157460 |
| 44 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.48910695 |
| 45 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.48552726 |
| 46 | SPI1_23127762_ChIP-Seq_K562_Human | 1.48538384 |
| 47 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.46815661 |
| 48 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.44652698 |
| 49 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.44578402 |
| 50 | MAF_26560356_Chip-Seq_TH1_Human | 1.44382969 |
| 51 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43515015 |
| 52 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42594352 |
| 53 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.38534406 |
| 54 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.37695274 |
| 55 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.37679320 |
| 56 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.37092391 |
| 57 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.36255935 |
| 58 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.36255935 |
| 59 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.36120404 |
| 60 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.32938407 |
| 61 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.31354425 |
| 62 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.29347280 |
| 63 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.28326268 |
| 64 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.27017178 |
| 65 | KDM2B_26808549_Chip-Seq_K562_Human | 1.26781655 |
| 66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.26616009 |
| 67 | ATF3_27146783_Chip-Seq_COLON_Human | 1.25089802 |
| 68 | MYB_26560356_Chip-Seq_TH2_Human | 1.22926185 |
| 69 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.22107456 |
| 70 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21371585 |
| 71 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.20249296 |
| 72 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20240339 |
| 73 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.13891094 |
| 74 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12275765 |
| 75 | MYC_22102868_ChIP-Seq_BL_Human | 1.12235187 |
| 76 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.12231375 |
| 77 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11130440 |
| 78 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10904292 |
| 79 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09918894 |
| 80 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.08974894 |
| 81 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.08974894 |
| 82 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.08668660 |
| 83 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08652110 |
| 84 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.08447148 |
| 85 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07341131 |
| 86 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06737870 |
| 87 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06672885 |
| 88 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.06431210 |
| 89 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.06200394 |
| 90 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.04441157 |
| 91 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.04126715 |
| 92 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.03491104 |
| 93 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.03449449 |
| 94 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.03336784 |
| 95 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.02525436 |
| 96 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.02017419 |
| 97 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.01872278 |
| 98 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01848607 |
| 99 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01596132 |
| 100 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01447890 |
| 101 | MAF_26560356_Chip-Seq_TH2_Human | 1.01267536 |
| 102 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.01117351 |
| 103 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01036932 |
| 104 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.00670819 |
| 105 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.99834270 |
| 106 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.99831028 |
| 107 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.99043622 |
| 108 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97395793 |
| 109 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.97042791 |
| 110 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.96654510 |
| 111 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.96551884 |
| 112 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.96248267 |
| 113 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.96137969 |
| 114 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.96037188 |
| 115 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95988070 |
| 116 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.95796876 |
| 117 | * MYB_26560356_Chip-Seq_TH1_Human | 0.95739953 |
| 118 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.95651221 |
| 119 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.95528817 |
| 120 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94785309 |
| 121 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.93801367 |
| 122 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.93550654 |
| 123 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93388157 |
| 124 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.92706486 |
| 125 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.91505096 |
| 126 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.90932144 |
| 127 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90252817 |
| 128 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90158886 |
| 129 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.88227780 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.08041096 |
| 2 | MP0003436_decreased_susceptibility_to | 3.54139872 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.19140154 |
| 4 | MP0006082_CNS_inflammation | 2.76683071 |
| 5 | MP0002419_abnormal_innate_immunity | 2.74738639 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 2.71569461 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.65781960 |
| 8 | MP0004510_myositis | 2.62398592 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 2.58103196 |
| 10 | * MP0009785_altered_susceptibility_to | 2.55032806 |
| 11 | MP0010352_gastrointestinal_tract_polyps | 2.41164415 |
| 12 | MP0001533_abnormal_skeleton_physiology | 2.40846721 |
| 13 | MP0002139_abnormal_hepatobiliary_system | 2.40762920 |
| 14 | * MP0005000_abnormal_immune_tolerance | 2.35615085 |
| 15 | MP0003724_increased_susceptibility_to | 2.30984075 |
| 16 | MP0004947_skin_inflammation | 2.27113294 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.18810800 |
| 18 | * MP0005025_abnormal_response_to | 2.12018657 |
| 19 | MP0003566_abnormal_cell_adhesion | 2.09544130 |
| 20 | MP0003172_abnormal_lysosome_physiology | 2.04477136 |
| 21 | MP0003448_altered_tumor_morphology | 2.02503378 |
| 22 | MP0009840_abnormal_foam_cell | 2.00465971 |
| 23 | MP0002452_abnormal_antigen_presenting | 2.00117784 |
| 24 | MP0005451_abnormal_body_composition | 1.95201808 |
| 25 | MP0001790_abnormal_immune_system | 1.92891800 |
| 26 | MP0005387_immune_system_phenotype | 1.92891800 |
| 27 | MP0009278_abnormal_bone_marrow | 1.90688970 |
| 28 | * MP0000343_altered_response_to | 1.84850430 |
| 29 | MP0005023_abnormal_wound_healing | 1.82491989 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.80630233 |
| 31 | MP0001853_heart_inflammation | 1.76934908 |
| 32 | MP0008260_abnormal_autophagy | 1.76343707 |
| 33 | MP0003300_gastrointestinal_ulcer | 1.74830074 |
| 34 | * MP0002723_abnormal_immune_serum | 1.70603654 |
| 35 | MP0002998_abnormal_bone_remodeling | 1.70086503 |
| 36 | MP0003191_abnormal_cellular_cholesterol | 1.69549643 |
| 37 | MP0000604_amyloidosis | 1.67818773 |
| 38 | MP0005257_abnormal_intraocular_pressure | 1.66709121 |
| 39 | MP0003075_altered_response_to | 1.64617849 |
| 40 | MP0001800_abnormal_humoral_immune | 1.63435731 |
| 41 | MP0000685_abnormal_immune_system | 1.59013267 |
| 42 | * MP0002405_respiratory_system_inflammati | 1.57899497 |
| 43 | MP0000858_altered_metastatic_potential | 1.56961621 |
| 44 | * MP0001845_abnormal_inflammatory_respons | 1.55364933 |
| 45 | MP0005164_abnormal_response_to | 1.54051266 |
| 46 | MP0001958_emphysema | 1.53457911 |
| 47 | MP0005076_abnormal_cell_differentiation | 1.52699976 |
| 48 | MP0001819_abnormal_immune_cell | 1.52510615 |
| 49 | MP0010307_abnormal_tumor_latency | 1.51654020 |
| 50 | MP0009764_decreased_sensitivity_to | 1.51084024 |
| 51 | MP0002420_abnormal_adaptive_immunity | 1.50460288 |
| 52 | MP0003091_abnormal_cell_migration | 1.47042857 |
| 53 | MP0005390_skeleton_phenotype | 1.40442771 |
| 54 | MP0003453_abnormal_keratinocyte_physiol | 1.39005831 |
| 55 | MP0003279_aneurysm | 1.36774508 |
| 56 | MP0003329_amyloid_beta_deposits | 1.35509184 |
| 57 | MP0002933_joint_inflammation | 1.35112443 |
| 58 | * MP0008469_abnormal_protein_level | 1.34643817 |
| 59 | MP0004858_abnormal_nervous_system | 1.34263973 |
| 60 | MP0005275_abnormal_skin_tensile | 1.28429070 |
| 61 | MP0005671_abnormal_response_to | 1.28237055 |
| 62 | MP0002254_reproductive_system_inflammat | 1.23915420 |
| 63 | MP0005397_hematopoietic_system_phenotyp | 1.20328930 |
| 64 | MP0001545_abnormal_hematopoietic_system | 1.20328930 |
| 65 | MP0010155_abnormal_intestine_physiology | 1.18907607 |
| 66 | * MP0003186_abnormal_redox_activity | 1.17881771 |
| 67 | MP0002877_abnormal_melanocyte_morpholog | 1.16377411 |
| 68 | MP0005166_decreased_susceptibility_to | 1.15516703 |
| 69 | MP0001851_eye_inflammation | 1.15432847 |
| 70 | MP0008004_abnormal_stomach_pH | 1.08850835 |
| 71 | MP0003828_pulmonary_edema | 1.08667182 |
| 72 | MP0002138_abnormal_hepatobiliary_system | 1.07287822 |
| 73 | * MP0009333_abnormal_splenocyte_physiolog | 1.05973136 |
| 74 | MP0000920_abnormal_myelination | 1.05028556 |
| 75 | MP0003656_abnormal_erythrocyte_physiolo | 1.01169543 |
| 76 | MP0005365_abnormal_bile_salt | 0.98977647 |
| 77 | MP0000465_gastrointestinal_hemorrhage | 0.98652694 |
| 78 | * MP0000716_abnormal_immune_system | 0.97724408 |
| 79 | MP0003795_abnormal_bone_structure | 0.96854817 |
| 80 | MP0002295_abnormal_pulmonary_circulatio | 0.95080109 |
| 81 | MP0000249_abnormal_blood_vessel | 0.94648626 |
| 82 | MP0000750_abnormal_muscle_regeneration | 0.89880101 |
| 83 | MP0009763_increased_sensitivity_to | 0.89086679 |
| 84 | MP0002398_abnormal_bone_marrow | 0.88992924 |
| 85 | * MP0000689_abnormal_spleen_morphology | 0.88868240 |
| 86 | MP0000569_abnormal_digit_pigmentation | 0.88493281 |
| 87 | MP0004272_abnormal_basement_membrane | 0.87493240 |
| 88 | MP0000767_abnormal_smooth_muscle | 0.87279497 |
| 89 | MP0004883_abnormal_blood_vessel | 0.86596864 |
| 90 | MP0001542_abnormal_bone_strength | 0.85501410 |
| 91 | MP0003806_abnormal_nucleotide_metabolis | 0.84381583 |
| 92 | MP0005167_abnormal_blood-brain_barrier | 0.83726078 |
| 93 | * MP0002429_abnormal_blood_cell | 0.83321648 |
| 94 | MP0001243_abnormal_dermal_layer | 0.83073252 |
| 95 | MP0003183_abnormal_peptide_metabolism | 0.81553325 |
| 96 | MP0002006_tumorigenesis | 0.81285784 |
| 97 | MP0003690_abnormal_glial_cell | 0.80759207 |
| 98 | * MP0002722_abnormal_immune_system | 0.80353737 |
| 99 | MP0006054_spinal_hemorrhage | 0.80242489 |
| 100 | MP0005310_abnormal_salivary_gland | 0.79285108 |
| 101 | MP0003634_abnormal_glial_cell | 0.79191205 |
| 102 | MP0003195_calcinosis | 0.79069078 |
| 103 | MP0000733_abnormal_muscle_development | 0.78331448 |
| 104 | MP0002796_impaired_skin_barrier | 0.77499673 |
| 105 | MP0005165_increased_susceptibility_to | 0.75328613 |
| 106 | MP0003045_fibrosis | 0.74882177 |
| 107 | MP0001849_ear_inflammation | 0.71089957 |
| 108 | * MP0005595_abnormal_vascular_smooth | 0.71038770 |
| 109 | MP0002896_abnormal_bone_mineralization | 0.70944880 |
| 110 | MP0000371_diluted_coat_color | 0.70122109 |
| 111 | MP0004808_abnormal_hematopoietic_stem | 0.68875108 |
| 112 | MP0005197_abnormal_uvea_morphology | 0.66744413 |
| 113 | MP0005503_abnormal_tendon_morphology | 0.66567592 |
| 114 | MP0001915_intracranial_hemorrhage | 0.66238626 |
| 115 | MP0002332_abnormal_exercise_endurance | 0.65757234 |
| 116 | MP0005319_abnormal_enzyme/_coenzyme | 0.64992389 |
| 117 | MP0001663_abnormal_digestive_system | 0.62757330 |
| 118 | * MP0000609_abnormal_liver_physiology | 0.62712049 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.58306956 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.52993261 |
| 3 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.07760177 |
| 4 | Increased cerebral lipofuscin (HP:0011813) | 5.05616901 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.70858739 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.56456741 |
| 7 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.40903065 |
| 8 | Vacuolated lymphocytes (HP:0001922) | 4.11453805 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 4.07582488 |
| 10 | Vertebral compression fractures (HP:0002953) | 3.94777022 |
| 11 | Orchitis (HP:0100796) | 3.90664363 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.89999975 |
| 13 | Stomatitis (HP:0010280) | 3.70615633 |
| 14 | Myositis (HP:0100614) | 3.64745338 |
| 15 | Mediastinal lymphadenopathy (HP:0100721) | 3.64236467 |
| 16 | Peritonitis (HP:0002586) | 3.62034521 |
| 17 | Neurofibrillary tangles (HP:0002185) | 3.53250422 |
| 18 | Nuclear cataract (HP:0100018) | 3.52521818 |
| 19 | Dysostosis multiplex (HP:0000943) | 3.49511165 |
| 20 | Tetraparesis (HP:0002273) | 3.43807100 |
| 21 | Axonal loss (HP:0003447) | 3.43292227 |
| 22 | Mutism (HP:0002300) | 3.43119097 |
| 23 | Autoimmune thrombocytopenia (HP:0001973) | 3.24929862 |
| 24 | Retrobulbar optic neuritis (HP:0100654) | 3.24619897 |
| 25 | Optic neuritis (HP:0100653) | 3.24619897 |
| 26 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.18037403 |
| 27 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.18037403 |
| 28 | Abnormality of glycolipid metabolism (HP:0010969) | 3.18037403 |
| 29 | Interstitial pulmonary disease (HP:0006530) | 3.17469069 |
| 30 | Gingivitis (HP:0000230) | 3.16415382 |
| 31 | Myocardial infarction (HP:0001658) | 3.14969968 |
| 32 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.06956596 |
| 33 | Mucopolysacchariduria (HP:0008155) | 3.06956596 |
| 34 | Premature rupture of membranes (HP:0001788) | 3.02577076 |
| 35 | Protrusio acetabuli (HP:0003179) | 2.93489861 |
| 36 | Disinhibition (HP:0000734) | 2.89078799 |
| 37 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.88059203 |
| 38 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.88059203 |
| 39 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.88059203 |
| 40 | Chronic obstructive pulmonary disease (HP:0006510) | 2.86656830 |
| 41 | Obstructive lung disease (HP:0006536) | 2.86656830 |
| 42 | Cerebral inclusion bodies (HP:0100314) | 2.79729144 |
| 43 | Purpura (HP:0000979) | 2.79025893 |
| 44 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.71845113 |
| 45 | Complement deficiency (HP:0004431) | 2.70584925 |
| 46 | Cervical subluxation (HP:0003308) | 2.63417432 |
| 47 | Glomerulonephritis (HP:0000099) | 2.60356218 |
| 48 | Recurrent skin infections (HP:0001581) | 2.60005768 |
| 49 | Urticaria (HP:0001025) | 2.58770528 |
| 50 | Cerebral aneurysm (HP:0004944) | 2.58657883 |
| 51 | Cellulitis (HP:0100658) | 2.53170430 |
| 52 | Apathy (HP:0000741) | 2.47769422 |
| 53 | Neuronal loss in central nervous system (HP:0002529) | 2.45353228 |
| 54 | Diminished motivation (HP:0000745) | 2.44676076 |
| 55 | Loss of speech (HP:0002371) | 2.43402837 |
| 56 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.42137834 |
| 57 | Pustule (HP:0200039) | 2.39198555 |
| 58 | Hematochezia (HP:0002573) | 2.36218501 |
| 59 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.34641175 |
| 60 | Osteolytic defects of the hand bones (HP:0009699) | 2.34641175 |
| 61 | Vasculitis (HP:0002633) | 2.29423625 |
| 62 | Pulmonary infiltrates (HP:0002113) | 2.27342670 |
| 63 | Progressive neurologic deterioration (HP:0002344) | 2.26040107 |
| 64 | Abnormality of proline metabolism (HP:0010907) | 2.24222339 |
| 65 | Hydroxyprolinuria (HP:0003080) | 2.24222339 |
| 66 | Recurrent fungal infections (HP:0002841) | 2.23918066 |
| 67 | Thick nail (HP:0001805) | 2.20667238 |
| 68 | Amyloidosis (HP:0011034) | 2.16524551 |
| 69 | Nausea (HP:0002018) | 2.16375458 |
| 70 | Retinal atrophy (HP:0001105) | 2.14653769 |
| 71 | Polycythemia (HP:0001901) | 2.14339331 |
| 72 | Nephritis (HP:0000123) | 2.13436796 |
| 73 | Arterial thrombosis (HP:0004420) | 2.12943867 |
| 74 | Prolonged neonatal jaundice (HP:0006579) | 2.12475871 |
| 75 | Prostate neoplasm (HP:0100787) | 2.10242271 |
| 76 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.08000711 |
| 77 | Pathologic fracture (HP:0002756) | 2.06085982 |
| 78 | Supranuclear gaze palsy (HP:0000605) | 2.05039894 |
| 79 | Leukocytosis (HP:0001974) | 2.04252431 |
| 80 | Dilatation of the ascending aorta (HP:0005111) | 2.04245876 |
| 81 | Abnormality of complement system (HP:0005339) | 2.04004373 |
| 82 | Bone pain (HP:0002653) | 2.02685182 |
| 83 | Abnormality of the pericardium (HP:0001697) | 2.00361401 |
| 84 | Thoracic kyphosis (HP:0002942) | 2.00277546 |
| 85 | Dementia (HP:0000726) | 1.99932137 |
| 86 | Osteomyelitis (HP:0002754) | 1.98794719 |
| 87 | Increased density of long bones (HP:0006392) | 1.98783278 |
| 88 | Progressive visual loss (HP:0000529) | 1.97696724 |
| 89 | Increased serum ferritin (HP:0003281) | 1.95800538 |
| 90 | Abnormality of the nasal mucosa (HP:0000433) | 1.95498753 |
| 91 | Basal ganglia calcification (HP:0002135) | 1.94642012 |
| 92 | Ulnar bowing (HP:0003031) | 1.94548684 |
| 93 | Aortic aneurysm (HP:0004942) | 1.93913893 |
| 94 | Inappropriate behavior (HP:0000719) | 1.93496772 |
| 95 | Conjunctival telangiectasia (HP:0000524) | 1.93410027 |
| 96 | Cardiomegaly (HP:0001640) | 1.92808747 |
| 97 | Increased IgE level (HP:0003212) | 1.91161007 |
| 98 | Peripheral demyelination (HP:0011096) | 1.90747253 |
| 99 | Hepatosplenomegaly (HP:0001433) | 1.90036392 |
| 100 | Personality changes (HP:0000751) | 1.89787547 |
| 101 | Aortic dissection (HP:0002647) | 1.88513839 |
| 102 | Abnormality of the peritoneum (HP:0002585) | 1.88203479 |
| 103 | Joint stiffness (HP:0001387) | 1.87167505 |
| 104 | Abnormality of iron homeostasis (HP:0011031) | 1.86727407 |
| 105 | Upper limb amyotrophy (HP:0009129) | 1.86122132 |
| 106 | Distal upper limb amyotrophy (HP:0007149) | 1.86122132 |
| 107 | Global brain atrophy (HP:0002283) | 1.85644347 |
| 108 | Metaphyseal irregularity (HP:0003025) | 1.85322296 |
| 109 | Asymmetric septal hypertrophy (HP:0001670) | 1.85276751 |
| 110 | Emphysema (HP:0002097) | 1.85226732 |
| 111 | Spondylolisthesis (HP:0003302) | 1.85217775 |
| 112 | Malnutrition (HP:0004395) | 1.84064054 |
| 113 | Petechiae (HP:0000967) | 1.82962585 |
| 114 | Esophageal varix (HP:0002040) | 1.82957820 |
| 115 | Keratoconjunctivitis sicca (HP:0001097) | 1.82351426 |
| 116 | Spontaneous hematomas (HP:0007420) | 1.81663032 |
| 117 | Achilles tendon contracture (HP:0001771) | 1.79784192 |
| 118 | Periodontitis (HP:0000704) | 1.79724986 |
| 119 | Xanthomatosis (HP:0000991) | 1.78954807 |
| 120 | Upper motor neuron abnormality (HP:0002127) | 1.78425835 |
| 121 | Agnosia (HP:0010524) | 1.78388733 |
| 122 | Poor head control (HP:0002421) | 1.77790098 |
| 123 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.77706366 |
| 124 | Hand muscle atrophy (HP:0009130) | 1.77590218 |
| 125 | Anorexia (HP:0002039) | 1.76874811 |
| 126 | Recurrent viral infections (HP:0004429) | 1.76635946 |
| 127 | Mucosal telangiectasiae (HP:0100579) | 1.75392295 |
| 128 | Increased CSF protein (HP:0002922) | 1.75204081 |
| 129 | Distal lower limb muscle weakness (HP:0009053) | 1.74923233 |
| 130 | Fused cervical vertebrae (HP:0002949) | 1.74035434 |
| 131 | Episodic fever (HP:0001954) | 1.71598507 |
| 132 | Acrocyanosis (HP:0001063) | 1.68641212 |
| 133 | Restrictive lung disease (HP:0002091) | 1.67790382 |
| 134 | Hemoptysis (HP:0002105) | 1.66258751 |
| 135 | Ovoid vertebral bodies (HP:0003300) | 1.64511860 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.00223483 |
| 2 | TBK1 | 3.86829753 |
| 3 | BLK | 3.03250271 |
| 4 | PBK | 2.94219600 |
| 5 | IRAK3 | 2.72832557 |
| 6 | MAP3K14 | 2.66039125 |
| 7 | PRPF4B | 2.59837045 |
| 8 | RIPK4 | 2.36122345 |
| 9 | TRIB3 | 2.27985178 |
| 10 | PIM2 | 2.23034683 |
| 11 | TESK1 | 2.16447339 |
| 12 | TYK2 | 2.13324706 |
| 13 | IKBKB | 2.06372898 |
| 14 | BMX | 2.00087086 |
| 15 | EPHB1 | 1.98616719 |
| 16 | GRK7 | 1.96044130 |
| 17 | STK10 | 1.81440837 |
| 18 | KIT | 1.80856562 |
| 19 | IRAK4 | 1.79942797 |
| 20 | RPS6KA4 | 1.75758985 |
| 21 | IKBKE | 1.69837014 |
| 22 | MAP3K3 | 1.62756739 |
| 23 | MAP3K11 | 1.60597586 |
| 24 | NME2 | 1.58590587 |
| 25 | TTN | 1.52434738 |
| 26 | PKN2 | 1.50619713 |
| 27 | TGFBR2 | 1.45570814 |
| 28 | CDC42BPA | 1.42075645 |
| 29 | ABL2 | 1.40736782 |
| 30 | ERBB4 | 1.40221340 |
| 31 | CSK | 1.38099181 |
| 32 | MAP4K1 | 1.36186403 |
| 33 | LRRK2 | 1.33707800 |
| 34 | MAP2K3 | 1.30802092 |
| 35 | JAK3 | 1.30064949 |
| 36 | TIE1 | 1.29421139 |
| 37 | FGR | 1.24208100 |
| 38 | LIMK1 | 1.21147564 |
| 39 | ACVR1B | 1.20238610 |
| 40 | JAK1 | 1.19829262 |
| 41 | EPHA3 | 1.18438855 |
| 42 | CHUK | 1.16009305 |
| 43 | PTK6 | 1.15926263 |
| 44 | SCYL2 | 1.15652550 |
| 45 | HCK | 1.13025664 |
| 46 | CSF1R | 1.10827097 |
| 47 | MARK3 | 1.09550828 |
| 48 | DDR2 | 1.09202755 |
| 49 | MOS | 1.09166322 |
| 50 | TESK2 | 1.08361005 |
| 51 | KSR2 | 1.06689147 |
| 52 | ICK | 1.04733810 |
| 53 | PIM1 | 1.03215748 |
| 54 | TAOK2 | 1.02273526 |
| 55 | PAK4 | 1.01819364 |
| 56 | MST1R | 0.99270310 |
| 57 | ZAP70 | 0.97602693 |
| 58 | RIPK1 | 0.92681441 |
| 59 | TAOK1 | 0.90891587 |
| 60 | CAMKK2 | 0.89366428 |
| 61 | PRKG2 | 0.86979942 |
| 62 | KDR | 0.82625940 |
| 63 | EPHB2 | 0.82295339 |
| 64 | FGFR4 | 0.81744678 |
| 65 | MAP3K5 | 0.79011847 |
| 66 | TRPM7 | 0.78277418 |
| 67 | SIK3 | 0.78184052 |
| 68 | EGFR | 0.77597350 |
| 69 | MAP3K1 | 0.77359758 |
| 70 | MATK | 0.76410834 |
| 71 | IRAK2 | 0.76288890 |
| 72 | PRKD2 | 0.75957794 |
| 73 | PDPK1 | 0.75488058 |
| 74 | ALK | 0.75425683 |
| 75 | LYN | 0.74579754 |
| 76 | MAP3K8 | 0.73036249 |
| 77 | PIK3CG | 0.71263319 |
| 78 | CDK6 | 0.70711511 |
| 79 | JAK2 | 0.70409806 |
| 80 | CDK12 | 0.67562957 |
| 81 | NEK9 | 0.67313780 |
| 82 | MAP3K13 | 0.66192896 |
| 83 | ABL1 | 0.66142465 |
| 84 | MET | 0.65839815 |
| 85 | TGFBR1 | 0.65410622 |
| 86 | LCK | 0.64769655 |
| 87 | DAPK3 | 0.64526593 |
| 88 | PDGFRB | 0.63647438 |
| 89 | RPS6KL1 | 0.63244808 |
| 90 | RPS6KC1 | 0.63244808 |
| 91 | PTK2B | 0.63069793 |
| 92 | SYK | 0.62055730 |
| 93 | LATS2 | 0.61926662 |
| 94 | CAMK1G | 0.61650709 |
| 95 | PDGFRA | 0.61552681 |
| 96 | TXK | 0.60253720 |
| 97 | MST4 | 0.59858183 |
| 98 | MAP3K10 | 0.59575382 |
| 99 | PAK2 | 0.58131595 |
| 100 | MAP3K6 | 0.57751323 |
| 101 | PDK2 | 0.56820820 |
| 102 | TYRO3 | 0.56554981 |
| 103 | FES | 0.56446574 |
| 104 | RPS6KA2 | 0.55274199 |
| 105 | SMG1 | 0.54885078 |
| 106 | MARK2 | 0.54722520 |
| 107 | MAPKAPK2 | 0.52337694 |
| 108 | PTK2 | 0.52239291 |
| 109 | PRKCD | 0.52092466 |
| 110 | MAPK7 | 0.50509311 |
| 111 | EPHA2 | 0.50471873 |
| 112 | MAPK12 | 0.50413377 |
| 113 | IRAK1 | 0.49631329 |
| 114 | SIK1 | 0.49599256 |
| 115 | BTK | 0.47632653 |
| 116 | FGFR3 | 0.46396599 |
| 117 | TAOK3 | 0.45441592 |
| 118 | RPS6KA6 | 0.45367096 |
| 119 | PAK1 | 0.44108724 |
| 120 | STK4 | 0.42996994 |
| 121 | CAMK1D | 0.42328606 |
| 122 | PDK1 | 0.42218181 |
| 123 | BMPR2 | 0.41209932 |
| 124 | STK3 | 0.40842721 |
| 125 | MAPK4 | 0.40760563 |
| 126 | MAP2K1 | 0.40725820 |
| 127 | INSR | 0.40517723 |
| 128 | ERBB3 | 0.40050434 |
| 129 | ARAF | 0.39274449 |
| 130 | ADRBK2 | 0.39051384 |
| 131 | GSK3A | 0.38718985 |
| 132 | MAPKAPK3 | 0.38128114 |
| 133 | PRKAA2 | 0.35955088 |
| 134 | DYRK1B | 0.34221375 |
| 135 | DYRK3 | 0.33963860 |
| 136 | MAP2K6 | 0.32104646 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.44867881 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.09544406 |
| 3 | Legionellosis_Homo sapiens_hsa05134 | 2.80922643 |
| 4 | Malaria_Homo sapiens_hsa05144 | 2.73812601 |
| 5 | Lysosome_Homo sapiens_hsa04142 | 2.56517767 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.43693908 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.42692043 |
| 8 | Pertussis_Homo sapiens_hsa05133 | 2.37891431 |
| 9 | Tuberculosis_Homo sapiens_hsa05152 | 2.26337744 |
| 10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.22934564 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.18122656 |
| 12 | Phagosome_Homo sapiens_hsa04145 | 2.13447937 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.09016009 |
| 14 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.06410294 |
| 15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.03830325 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.02914770 |
| 17 | Salmonella infection_Homo sapiens_hsa05132 | 1.93166830 |
| 18 | Shigellosis_Homo sapiens_hsa05131 | 1.77598188 |
| 19 | Apoptosis_Homo sapiens_hsa04210 | 1.60510404 |
| 20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.60203906 |
| 21 | Asthma_Homo sapiens_hsa05310 | 1.59931705 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.52240447 |
| 23 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.51363645 |
| 24 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.50237419 |
| 25 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.48528843 |
| 26 | Measles_Homo sapiens_hsa05162 | 1.47907703 |
| 27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.46901103 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.46798810 |
| 29 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.44185115 |
| 30 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.42805917 |
| 31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.42776103 |
| 32 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.42097756 |
| 33 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.38775917 |
| 34 | Amoebiasis_Homo sapiens_hsa05146 | 1.38442726 |
| 35 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.38420057 |
| 36 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.34517122 |
| 37 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.26684514 |
| 38 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.25864864 |
| 39 | Allograft rejection_Homo sapiens_hsa05330 | 1.22934511 |
| 40 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.21735088 |
| 41 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.15136025 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.13865895 |
| 43 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.09739641 |
| 44 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.07795724 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 1.05659993 |
| 46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.04404853 |
| 47 | Prion diseases_Homo sapiens_hsa05020 | 1.04360123 |
| 48 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.00703469 |
| 49 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.00358091 |
| 50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.98150115 |
| 51 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.95712450 |
| 52 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.95283417 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.95086536 |
| 54 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.91885001 |
| 55 | Viral myocarditis_Homo sapiens_hsa05416 | 0.91104709 |
| 56 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.90167058 |
| 57 | Hepatitis C_Homo sapiens_hsa05160 | 0.89309944 |
| 58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.88039268 |
| 59 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.86609371 |
| 60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.86484774 |
| 61 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.81892470 |
| 62 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.81852121 |
| 63 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.81733472 |
| 64 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80029719 |
| 65 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.78582004 |
| 66 | Bladder cancer_Homo sapiens_hsa05219 | 0.77022566 |
| 67 | Focal adhesion_Homo sapiens_hsa04510 | 0.71630034 |
| 68 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.69398043 |
| 69 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.66659815 |
| 70 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.66603198 |
| 71 | * HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.65573529 |
| 72 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.65054913 |
| 73 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.64023426 |
| 74 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.63934750 |
| 75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63340246 |
| 76 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.61658398 |
| 77 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.58228026 |
| 78 | Endocytosis_Homo sapiens_hsa04144 | 0.57470808 |
| 79 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.56358103 |
| 80 | Adherens junction_Homo sapiens_hsa04520 | 0.55517876 |
| 81 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.54402566 |
| 82 | Platelet activation_Homo sapiens_hsa04611 | 0.53577608 |
| 83 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.52992443 |
| 84 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.52712097 |
| 85 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.52141090 |
| 86 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.49774060 |
| 87 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.47819592 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.46897098 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46785465 |
| 90 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.46164088 |
| 91 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.45955750 |
| 92 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.45929866 |
| 93 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45439076 |
| 94 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.45186969 |
| 95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43620866 |
| 96 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.43530253 |
| 97 | HTLV-I infection_Homo sapiens_hsa05166 | 0.42456736 |
| 98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.42027847 |
| 99 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.40505952 |
| 100 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.40043519 |
| 101 | * Mineral absorption_Homo sapiens_hsa04978 | 0.38232806 |
| 102 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.34643254 |
| 103 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.33784888 |
| 104 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.33709718 |
| 105 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.33617675 |
| 106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.33492863 |
| 107 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.32796651 |
| 108 | Prostate cancer_Homo sapiens_hsa05215 | 0.31813238 |
| 109 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.31482470 |
| 110 | Melanoma_Homo sapiens_hsa05218 | 0.31408290 |
| 111 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30077567 |
| 112 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.29402672 |
| 113 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.28095383 |
| 114 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.27457934 |
| 115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.27365781 |
| 116 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.24419098 |

